The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of circulating tumor DNA (ctDNA) to affect the adjuvant or post-adjuvant treatment of patients with stage III and high-risk stage II resected colon cancer: The ERASE-CRC project by GONO.
 
Veronica Conca
No Relationships to Disclose
 
Guglielmo Vetere
No Relationships to Disclose
 
Roberto Moretto
No Relationships to Disclose
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Carlotta Antoniotti
Honoraria - Merck
Travel, Accommodations, Expenses - Merck
 
Marco Maria Germani
No Relationships to Disclose
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi-Sankyo; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Janssen; Merck Serono; MSD Oncology; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre
 
Alessandro Bittoni
No Relationships to Disclose
 
Martina Carullo
No Relationships to Disclose
 
Lisa Salvatore
Honoraria - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Incyte; Merck Serono; MSD; Pierre Fabre; SERVIER; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Incyte; Merck Serono; MSD; Pierre Fabre; SERVIER; Takeda
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Pierre Fabre; SERVIER
 
Alessandra Boccaccino
Honoraria - Amgen
Travel, Accommodations, Expenses - Amgen; Gilead Sciences
 
Monica Ronzoni
No Relationships to Disclose
 
Gianmarco Ricagno
No Relationships to Disclose
 
Ilaria Toma
No Relationships to Disclose
 
Samanta Cupini
No Relationships to Disclose
 
Tiziana Pia Latiano
No Relationships to Disclose
 
Giuseppina Arcangeli
No Relationships to Disclose
 
Gianluca Masi
Consulting or Advisory Role - AstraZeneca; Eisai; MSD Oncology; Roche; Roche
Research Funding - Terumo (Inst); Terumo (Inst)
Patents, Royalties, Other Intellectual Property - Terumo (Inst)
 
Matteo Fassan
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; AstraZeneca; GlaxoSmithKline; Incyte; Janssen; Lilly; MSD Oncology; Novartis; Pierre Fabre; Roche
Research Funding - Astellas Pharma; Diaceutics; Macrophage Pharma; QED Therapeutics
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Nordic Bioscience; Pierre Fabre; Roche
Speakers' Bureau - Merck; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER